Skip to main content
Skip to section navigation
Skip to footer
About Us
Our Mission
Leadership
Partnerships
Careers
Contact Us
Our Science
SCY-247
Ibrexafungerp
Life-threatening Infections
Pipeline
Publications and Presentations
News
News
Events
Careers
Investors
Press Releases
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Leadership
Contacts
FAQ
Tear Sheet
Financial Info
Overview
Financial Results
Key Ratios
Investor Calculator
Stock Info
Quote
Charts
Historical Data
Analyst Coverage
Investor Calculator
SEC Filings
Overview
All SEC Filings
Annual Filings
Quarterly Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Year
All Years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Category
All Releases
Financial Releases
Jun 10, 2015 8:30am EDT
SCYNEXIS, Inc. Announces Changes to Board of Directors
Jun 05, 2015 8:30am EDT
SCYNEXIS, Inc. Announces New Employment Inducement Grant
May 26, 2015 8:30am EDT
SCYNEXIS, Inc. to Present at Jefferies 2015 Healthcare Conference
May 15, 2015 8:30am EDT
SCYNEXIS, Inc. Reports First Quarter 2015 Financial Results
May 14, 2015 8:30am EDT
SCYNEXIS Appoints David Angulo, M.D., as Chief Medical Officer
Apr 22, 2015 10:30pm EDT
SCYNEXIS Announces Pricing of Public Offering of Common Stock
Apr 20, 2015 7:40am EDT
SCYNEXIS Announces Launch of Public Offering of Common Stock
Mar 30, 2015 8:30am EDT
SCYNEXIS, Inc. Reports Full Year 2014 Financial Results
Mar 12, 2015 8:30am EDT
SCYNEXIS, Inc. to Present at Jefferies 2015 Antibiotic Summit
Feb 27, 2015 8:30am EST
SCYNEXIS, Inc. Appoints Steven C. Gilman, Ph.D., to Board of Directors
Previous Page
arrow_back
Page
1
…
Page
25
Page
26
Page
27
Page
28
Page
29
Page
30
Page
31
Page
32
Page
33
Page
34
…
Page
36
Next Page
arrow_forward
rss_feed
News RSS
Email Alerts
Company Profile
Contacts
RSS News Feed
